{"title":"Awareness of menopause and menopause hormone therapy in India: perspectives of healthcare providers and consumers.","authors":"Meeta Meeta, Sujatha Guduru, Tanvir Tanvir, Akanshi Madan","doi":"10.1080/13697137.2025.2503876","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study was a dual-module approach that aimed to evaluate knowledge and concerns of healthcare providers (HCPs) about menopause hormone therapy (MHT) in under-resourced communities, and to understand the awareness and sources of information on menopause and MHT in these communities.</p><p><strong>Methods: </strong>The cross-sectional survey study consisted of two modules: the population module was administered offline and followed the computer-aided personal interview methodology; and the HCP module was an online, self-administered survey.</p><p><strong>Results: </strong>Out of 32,518 women surveyed from underprivileged communities, 50% were unaware of the effects of menopause, and 62% were unaware of the available treatment; if offered by the HCP, 48% were willing to take treatment. Responses from 1261 HCPs showed that systemic MHT was prescribed by 62.4% of HCPs and vaginal estrogen therapy by 86.0%. Although 95% of HCPs were aware of the indications, risks and benefits of MHT, 57% used alternative therapies as first-line therapy and 71% used them as an adjunct to MHT.</p><p><strong>Conclusions: </strong>There is a lack of awareness regarding the impact of menopause on health and on the use of MHT, and educational programs may encourage women to seek help. While HCPs are knowledgeable, hesitancy in the use of systemic MHT indicates the need for professional training programs to increase confidence in prescription writing.</p>","PeriodicalId":10213,"journal":{"name":"Climacteric","volume":" ","pages":"286-295"},"PeriodicalIF":2.9000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Climacteric","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13697137.2025.2503876","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study was a dual-module approach that aimed to evaluate knowledge and concerns of healthcare providers (HCPs) about menopause hormone therapy (MHT) in under-resourced communities, and to understand the awareness and sources of information on menopause and MHT in these communities.
Methods: The cross-sectional survey study consisted of two modules: the population module was administered offline and followed the computer-aided personal interview methodology; and the HCP module was an online, self-administered survey.
Results: Out of 32,518 women surveyed from underprivileged communities, 50% were unaware of the effects of menopause, and 62% were unaware of the available treatment; if offered by the HCP, 48% were willing to take treatment. Responses from 1261 HCPs showed that systemic MHT was prescribed by 62.4% of HCPs and vaginal estrogen therapy by 86.0%. Although 95% of HCPs were aware of the indications, risks and benefits of MHT, 57% used alternative therapies as first-line therapy and 71% used them as an adjunct to MHT.
Conclusions: There is a lack of awareness regarding the impact of menopause on health and on the use of MHT, and educational programs may encourage women to seek help. While HCPs are knowledgeable, hesitancy in the use of systemic MHT indicates the need for professional training programs to increase confidence in prescription writing.
期刊介绍:
Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women.
Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments.
The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.